Cargando…
Localized Non-melanoma Skin Cancer: Risk Factors of Post-surgical Relapse and Role of Postoperative Radiotherapy
The mainstay treatment of localized non-melanoma skin cancer (NMSC) is surgical excision or Mohs surgery. However, approximately 5% of patients with NMSC harbor high-risk clinicopathologic features for loco-regional recurrence, and distant metastasis. Prognostic factors such as close or positive mar...
Autores principales: | Caparrotti, Francesca, Troussier, Idriss, Ali, Abdirahman, Zilli, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546974/ https://www.ncbi.nlm.nih.gov/pubmed/33034759 http://dx.doi.org/10.1007/s11864-020-00792-2 |
Ejemplares similares
-
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer
por: Sanchez, Katherine, et al.
Publicado: (2023) -
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma
por: Zelin, Enrico, et al.
Publicado: (2021) -
Targeted Therapy and Immunotherapy for Melanoma in Japan
por: Namikawa, Kenjiro, et al.
Publicado: (2019) -
Autophagy Paradox: Strategizing Treatment Modality in Melanoma
por: Pangilinan, Christian, et al.
Publicado: (2023) -
Targeted Therapy for Melanomas Without BRAF V600 Mutations
por: Menzer, Christian, et al.
Publicado: (2022)